Romiplostim mitigates dose-limiting thrombocytopenia of erucic acid for adrenomyeloneuropathy.

The article focuses on a study related to erucic acid and adrenomyeloneuropathy. Topics discussed include a peroxisomal disorder of beta-oxidation resulting in tissue accumulation of long-chain of fatty acids, mutations in the ATP-binding cassette transporters, a delayed progression of neurological signs in early adrenoleucodystrophy due to dietary treatment.